LivaNova PLC Segment Expenditure Addition To Long Lived Assets
LivaNova PLC (LIVN) reported Segment Expenditure Addition To Long Lived Assets of $27.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-08-05
- LivaNova PLC segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $27.60M, a 58.85% increase year-over-year.
- LivaNova PLC segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $23.66M, a 129.63% increase year-over-year.
- LivaNova PLC segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $33.14M, a 111.42% increase year-over-year.
- LivaNova PLC segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $23.38M, a 66.08% increase year-over-year.
- LivaNova PLC segment expenditure addition to long lived assets for fiscal 2025 was $84.20M, a 68.56% increase from fiscal 2024.
- LivaNova PLC segment expenditure addition to long lived assets for fiscal 2024 was $49.95M, a 42.29% increase from fiscal 2023.
- LivaNova PLC segment expenditure addition to long lived assets for fiscal 2023 was $35.11M, a 32.02% increase from fiscal 2022.
- LivaNova PLC segment expenditure addition to long lived assets for fiscal 2022 was $26.59M, a 19.18% increase from fiscal 2021.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.60M 10-Q · filed 2026-08-05 | $51.26M 10-Q · filed 2026-08-05 | $84.40M derived: sum of 3 quarters · filed 2026-08-05 | $107.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $23.66M 10-Q · filed 2026-05-06 | $56.80M derived: sum of 2 quarters · filed 2026-05-06 | $80.19M derived: sum of 3 quarters · filed 2026-05-06 | $97.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $33.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $56.53M derived: sum of 2 quarters · filed 2026-02-25 | $73.90M derived: sum of 3 quarters · filed 2026-08-05 | $84.20M 10-K · filed 2026-02-25 |
| 2025-09-30 | $23.38M 10-Q · filed 2025-11-05 | $40.76M derived: sum of 2 quarters · filed 2026-08-05 | $51.06M 10-Q · filed 2025-11-05 | $66.74M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $17.37M 10-Q · filed 2026-08-05 | $27.68M 10-Q · filed 2026-08-05 | $43.35M derived: sum of 3 quarters · filed 2026-08-05 | $57.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $10.30M 10-Q · filed 2026-05-06 | $25.98M derived: sum of 2 quarters · filed 2026-05-06 | $40.06M derived: sum of 3 quarters · filed 2026-05-06 | $53.81M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $15.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $29.76M derived: sum of 2 quarters · filed 2026-02-25 | $43.51M derived: sum of 3 quarters · filed 2026-02-25 | $49.95M 10-K · filed 2026-02-25 |
| 2024-09-30 | $14.08M 10-Q · filed 2025-11-05 | $27.83M derived: sum of 2 quarters · filed 2025-11-05 | $34.28M 10-Q · filed 2025-11-05 | $47.30M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $13.75M 10-Q · filed 2025-08-06 | $20.20M 10-Q · filed 2025-08-06 | $33.22M derived: sum of 3 quarters · filed 2026-02-25 | $41.40M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $6.45M 10-Q · filed 2025-05-07 | $19.47M derived: sum of 2 quarters · filed 2026-02-25 | $27.65M derived: sum of 3 quarters · filed 2026-02-25 | $33.70M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $21.20M derived: sum of 2 quarters · filed 2026-02-25 | $27.26M derived: sum of 3 quarters · filed 2026-02-25 | $35.11M 10-K · filed 2026-02-25 |
| 2023-09-30 | $8.18M 10-Q · filed 2024-10-31 | $14.24M derived: sum of 2 quarters · filed 2024-10-31 | $22.09M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $6.05M 10-Q · filed 2024-08-01 | $13.91M 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | $7.85M 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | $26.59M 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $22.31M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |